Rationale for active vitamin D analog therapy in senile osteoporosis

Calcified Tissue International

Volumn 60, Issue 1, 1997, Pages 100-105

  Akesson K ^a   Lau, K H W ^a   Baylink, D J ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

BIOMECHANICS; BONE DENSITY; CALCIUM HOMEOSTASIS; CONFERENCE PAPER; ESTROGEN DEFICIENCY; HUMAN; HYPERPARATHYROIDISM; MINERALIZATION; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; VITAMIN METABOLISM;

AGED; AGING; CALCITRIOL; FEMALE; HUMANS; OSTEOPOROSIS;

EID: 0031023174     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900195     Document Type: Conference Paper

References (40)

1. 3 to calcitroic acid. Evidence for a pathway in kidney and bone involving 24-oxidation. Biochem J 262:173-80
2. 3 receptors: gene regulation and genetic circuitry. FASEB J 2:23043-23053
3. 3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 206:1188-1190
4. Nemere I, Zhou LX, Norman AW (1993) Nontranscriptional effects of steroid hormones. Receptor 3:277-291
5. Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240:889-895
6. 3 receptors. Cell 65:1255-1266
7. 3 receptor by parathyroid hormone (PTH) and PTH-like peptide in osteoblast-like cells. Biochem Biophys Res Comm 156:588-598
8. Reinhardt TA, Horst RL (1990) Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo. Endocrinology 137:942-948
9. Morrison NA, Qi JC, Tokita A, Kelly JP, Crofts L, Nguyen TV, Sambrook PH, Eisman JA (1994) Prediction of bone density from vitamin D receptor alleles. Nature 367:284-287
10. Looney JE, Yoon HK, Fischer M, Farley SM, Farley JR, Wergedal JE, Baylink DJ (1995) Lack of high prevalence of the BB vitamin D receptor genotype in severely osteoporotic women. J Clin Endocrinol Metab 80:2158-2162
11. Peacock M (1995) Vitamin D receptor gene alleles and osteoporosis: a contrasting view. J Bone Miner Res 10:1294-1297
12. 3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 4:506-512
13. Finkelman RD, Linkhart TA, Mohan S, Lau KHW, Baylink DJ, Bell NH (1991) Vitamin D deficiency causes a selective reduction in the deposition of transforming growth factor beta in rat bone: possible mechanism for impaired osteoinduction. Proc Natl Acad Sci 88:3657-3660
14. Chertow BS, Baylink DJ, Wergedal JE, Su MH, Norman AW (1975) Decrease in serum immunoreactive parathyroid hormone in rats and in PTH secretion in vitro by 1,25-dihydroxycholecalciferol. J Clin Invest 56:668-678
15. Toss G, Almqvist S, Larsson L, Zetterqvist H (1980) Vitamin D deficiency in welfare institutions for the aged. Acta Med Scand 208:87-89
16. Ooms ME, Lips P, Roos JC, Van der Vijgh WJ, Popp-Snijders C, Bezemer PD, Bouter LM (1995) Vitamin D status and sex hormone-binding globulin: determinants of bone turn-over and bone mineral density in elderly women. J Bone Miner Res 10:1177-1184
17. Francis RM, Peacock M (1987) Local action of oral 1,25-dihydroxycholecalciferol on calcium absorption in osteoporosis. Am J Clin Nutr 46:315-318
18. Brazier M, Kamel S, Maamer M, Agbomson F, Elesper I, Garabedian M, Desmet G, Sebert JL (1995) Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correlation. J Bone Miner Res 10:1753-1761
19. Lips P, Netelenbos JC, Jongen MJM, van Ginkel FC, Althuis AL, van Scheik CL, van der Vijgh WJ, Vermeiden JP, van der Meer C (1982) Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metab Bone Dis Rel Res 4:85-93
20. 3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327:1637-1642
21. Epstein S, Bryce G, Hinman JW, Miller ON, Riggs BL, Hui SL, Johnston CC Jr (1986) The influence of age on bone mineral regulating hormones. Bone 7:421-425
22. Slovik DM, Daly MA, Potts JT, Neer RM (1984) Renal 1,25-dihydroxyvitamin D, phosphaturic, and cyclic-AMP responses to intravenous synthetic human parathyroid hormone (1-34) administration in normal subjects. Clin Endocrinol (Oxf) 20:369-375
23. Slovik DM, Adams JS, Neer RM, Holick MF, Potts JT (1981) Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med 305:372-374
24. Ebeling PR, Sandgren ME, DiMagno EP, Lane AW, DeLuca HF, Riggs BL (1992) Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D and intestinal vitamin D receptor concentration in normal women. J Clin Endocrinol Metab 75:176-182
25. 2D in normal women. J Bone Miner Res 10(S1):162
26. 47Ca absorption in postmenopausal osteoporosis. J Clin Invest 44:1960-1967
27. Nordin BE, Wilkinson F, Marshall DH, Gallager JC, Williams A, Peacock M (1976) Calcium absorption in the elderly. Calcif Tissue Res 21(suppl):442-451
28. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF (1979) Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. Effect of age and dietary calcium. J Clin Invest 64:729-736
29. Heaney RP, Recker RR, Stegman MR, Moy AJ (1989) Calcium absorption in women: relationship to calcium intake, estrogen status and age. J Bone Miner Res 4:469-475
30. Eastell R, Yergey AL, Vieira NE, Cedel SL, Kumar R, Riggs BL (1991) Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: evidence of an age-related intestinal resistance to 1,25-dihydroxyvitamin D action. J Bone Miner Res 6:125-132
31. Ebeling PR, Yergey AL, Vieira NE, Burritt MF, O'Fallon WM, Kumar R, Riggs BL (1994) Influence of age on effects of endogenous 1,25-dihydroxyvitamin D on calcium absorption in normal women. Calcif Tissue Int 55(5):330-334
32. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G, Lundberg PA, Wilske J, Bengtsson BÅ (1995) Serum intact parathyroid hormone in a random population sample of men and women: relationship to anthropometry, life-style factors, blood pressure and vitamin D. Calcif Tissue Int 56:104-108
33. 3. J Clin Endocrinol Metab 79:211-216
34. Akesson K, Ljunghall S, Jonsson B, Sernbo I, Johnell O, Gärdsell P, Obrant KJ (1995) Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women. J Bone Miner Res 10:1823-1829
35. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD (1996) Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11:337-434
36. Stauffer M, Baylink D, Wergedal J, Rich C (1973) Decreased bone formation and mineralization, and enhanced resorption in calcium-deficient rats. Am J Physiol 225:269-276
37. 3 differentially regulates the production of IGF-I and IGFBP-4 in mouse osteoblasts. Endocrinology 129:3139-3142
38. Mohan S, Strong DD, Lempert UG, Tremollieres F, Wergedal JE, Baylink DJ (1992) Studies on the regulation of insulin-like growth factor binding protein (IGFBP)-3 and BP-4 production in human bone cells. Acta Endocrinol 127:555-564
39. Rosen C, Donahue LR, Hunter S, Holick M, Kavookjian H, Kirschenbaum A, Mohan S, Baylink DJ (1992) The 24/25-kDa serum insulin-like growth factor binding protein is increased in elderly women with hip and spine fractures. J Clin Endocrinol Metab 74:24-27
40. 3. J Biol Chem 256:7738-7740